MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 41 filers reported holding MEI PHARMA INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $53,968 | -15.5% | 235,773 | -10.1% | 0.00% | – |
| Q4 2022 | $63,887 | -72.7% | 262,261 | -56.6% | 0.00% | – |
| Q3 2022 | $234,000 | -37.8% | 604,927 | -2.8% | 0.00% | – |
| Q2 2022 | $376,000 | -21.2% | 622,227 | -21.5% | 0.00% | – |
| Q1 2022 | $477,000 | -78.1% | 792,250 | -2.8% | 0.00% | -100.0% |
| Q4 2021 | $2,177,000 | -2.9% | 815,029 | +0.4% | 0.00% | – |
| Q3 2021 | $2,241,000 | -7.4% | 812,010 | -4.4% | 0.00% | -100.0% |
| Q2 2021 | $2,420,000 | -5.0% | 849,029 | +14.3% | 0.00% | 0.0% |
| Q1 2021 | $2,548,000 | +20.4% | 742,736 | -7.4% | 0.00% | 0.0% |
| Q4 2020 | $2,117,000 | -10.0% | 801,917 | +6.4% | 0.00% | 0.0% |
| Q3 2020 | $2,352,000 | -14.4% | 753,768 | +13.2% | 0.00% | 0.0% |
| Q2 2020 | $2,749,000 | +390.0% | 665,692 | +91.2% | 0.00% | – |
| Q1 2020 | $561,000 | -9.1% | 348,230 | +40.1% | 0.00% | – |
| Q4 2019 | $617,000 | +39.6% | 248,605 | -5.6% | 0.00% | – |
| Q3 2019 | $442,000 | +13.6% | 263,265 | +68.8% | 0.00% | – |
| Q2 2019 | $389,000 | -25.3% | 156,001 | -8.2% | 0.00% | – |
| Q1 2019 | $521,000 | +23.8% | 169,944 | +6.7% | 0.00% | – |
| Q4 2018 | $421,000 | +9.1% | 159,301 | +78.3% | 0.00% | – |
| Q3 2018 | $386,000 | +26.6% | 89,363 | +15.5% | 0.00% | – |
| Q2 2018 | $305,000 | +224.5% | 77,352 | +71.4% | 0.00% | – |
| Q1 2018 | $94,000 | +3.3% | 45,128 | +4.3% | 0.00% | – |
| Q4 2017 | $91,000 | +264.0% | 43,265 | +370.3% | 0.00% | – |
| Q3 2017 | $25,000 | +4.2% | 9,200 | -9.8% | 0.00% | – |
| Q2 2017 | $24,000 | +84.6% | 10,200 | +24.4% | 0.00% | – |
| Q1 2017 | $13,000 | +8.3% | 8,200 | 0.0% | 0.00% | – |
| Q4 2016 | $12,000 | -14.3% | 8,200 | 0.0% | 0.00% | – |
| Q3 2016 | $14,000 | +250.0% | 8,200 | +156.2% | 0.00% | – |
| Q2 2016 | $4,000 | 0.0% | 3,200 | 0.0% | 0.00% | – |
| Q1 2016 | $4,000 | -33.3% | 3,200 | -13.5% | 0.00% | – |
| Q4 2015 | $6,000 | -33.3% | 3,700 | -33.9% | 0.00% | – |
| Q3 2015 | $9,000 | +200.0% | 5,600 | +180.0% | 0.00% | – |
| Q2 2015 | $3,000 | -62.5% | 2,000 | -50.0% | 0.00% | – |
| Q1 2015 | $8,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |